查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435019

抗寄生虫药市场：按药物类型、剂型、适应症、分销管道、最终用户划分 - 全球预测 2024-2030

Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年抗寄生虫药市场规模为204亿美元，预计2024年将达211.2亿美元，2030年将达到279.4亿美元，复合年增长率为4.59%。

全球抗寄生虫药市场

主要市场统计
基准年[2023] 204亿美元
预测年份 [2024] 211.2亿美元
预测年份 [2030] 279.4亿美元
复合年增长率（%） 4.59%
抗寄生虫药市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估抗寄生虫药物市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对抗寄生虫药物市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-抗寄生虫药市场的市场规模和预测是多少？

2-抗寄生虫药市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-抗寄生虫药市场的技术趋势和法律规范是什么？

4-抗寄生虫药市场主要供应商的市场占有率为何？

5-进入抗寄生虫药市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球寄生虫感染疾病的发生率和认识正在不断提高
      • 政府控制寄生虫感染的有利方法
      • 增加对研发活动的投资
    • 抑制因素
      • 药物研发需要大量资金
    • 机会
      • 多个监管机构核准的抗寄生虫药物激增
      • 新型抗寄生虫药厂商介绍
    • 任务
      • 与药物相关的副作用和风险
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章依药物类型分類的抗寄生虫药物市场

  • 驱虫药
  • 抗原虫药
  • 外寄生虫剂
  • 体内杀虫剂

第七章抗寄生虫药市场：依型态

  • 注射
  • 口服锭剂/胶囊
  • 局部霜

第八章以适应症分類的抗寄生虫药市场

  • 凿
  • 肠道寄生虫
  • 蝨子
  • 疟疾
  • 疥疮
  • 打钩

第九章抗寄生虫药市场：依通路

  • 离线
  • 在线的

第十章抗寄生虫药市场：依最终用户分类

  • 居家护理设施
  • 医院和诊所
  • 动物医院

第十一章美洲抗寄生虫药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区抗寄生虫药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲抗寄生虫药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第15章竞争组合

  • 主要公司简介
    • Adva Care Pharma
    • Algen Healthcare Ltd.
    • Amneal Pharmaceuticals LLC
    • Bayer AG
    • Ben Pharmaceuticals
    • Centurion Laboratories Private Limited
    • Cipla Ltd.
    • Consern Pharma Limited
    • Dr.Reddys Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fredun Group
    • Garcia Life Sciences
    • Glaxosmithkline PLC
    • Healthy Life Pharma Private Limited
    • Ipca Laboratories
    • Jackson Laboratories Pvt Ltd.
    • Mankind Pharma
    • Merck KgaA
    • Novartis AG
    • Sanofi
    • Soigner Pharma by Arlak Biotech
    • Sriwalls Health Care
    • Taj Life Sciences Pvt. Ltd.
    • Weefsel Pharma
    • Zydus Group
  • 主要产品系列

第十六章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-B1685377777A

[182 Pages Report] The Antiparasitic Drugs Market size was estimated at USD 20.40 billion in 2023 and expected to reach USD 21.12 billion in 2024, at a CAGR 4.59% to reach USD 27.94 billion by 2030.

Global Antiparasitic Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 20.40 billion
Estimated Year [2024] USD 21.12 billion
Forecast Year [2030] USD 27.94 billion
CAGR (%) 4.59%
Antiparasitic Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antiparasitic Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antiparasitic Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antiparasitic Drugs Market, highlighting leading vendors and their innovative profiles. These include Adva Care Pharma, Algen Healthcare Ltd., Amneal Pharmaceuticals LLC, Bayer AG, Ben Pharmaceuticals, Centurion Laboratories Private Limited, Cipla Ltd., Consern Pharma Limited, Dr.Reddys Laboratories Inc., F. Hoffmann-La Roche AG, Fredun Group, Garcia Life Sciences, Glaxosmithkline PLC, Healthy Life Pharma Private Limited, Ipca Laboratories, Jackson Laboratories Pvt Ltd., Mankind Pharma, Merck KgaA, Novartis AG, Sanofi, Soigner Pharma by Arlak Biotech, Sriwalls Health Care, Taj Life Sciences Pvt. Ltd., Weefsel Pharma, and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Antiparasitic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Anthelmintics
    • Antiprotozoals
    • Ectoparasiticides
    • Endoparaciticides
  • Form
    • Injections
    • Oral Tablets/Capsules
    • Topical Creams
  • Indication
    • Fleas
    • Intestinal Parasites
    • Lice
    • Malaria
    • Scabies
    • Ticks
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Home Care Facilities
    • Hospitals & Clinics
    • Veterinary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antiparasitic Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antiparasitic Drugs Market?

3. What are the technology trends and regulatory frameworks in the Antiparasitic Drugs Market?

4. What is the market share of the leading vendors in the Antiparasitic Drugs Market?

5. Which modes and strategic moves are suitable for entering the Antiparasitic Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antiparasitic Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence and awareness of parasite infection across the globe
      • 5.1.1.2. Favorable government initiatives for parasite infection management
      • 5.1.1.3. Increasing investment in research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of huge capital for drug development
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals for antiparasitic drugs from several regulatory authorities
      • 5.1.3.2. Introduction of novel antiparasitic drugs by manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects and risks associated with the drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antiparasitic Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Anthelmintics
  • 6.3. Antiprotozoals
  • 6.4. Ectoparasiticides
  • 6.5. Endoparaciticides

7. Antiparasitic Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral Tablets/Capsules
  • 7.4. Topical Creams

8. Antiparasitic Drugs Market, by Indication

  • 8.1. Introduction
  • 8.2. Fleas
  • 8.3. Intestinal Parasites
  • 8.4. Lice
  • 8.5. Malaria
  • 8.6. Scabies
  • 8.7. Ticks

9. Antiparasitic Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Antiparasitic Drugs Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care Facilities
  • 10.3. Hospitals & Clinics
  • 10.4. Veterinary Clinics

11. Americas Antiparasitic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antiparasitic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antiparasitic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Adva Care Pharma
    • 15.1.2. Algen Healthcare Ltd.
    • 15.1.3. Amneal Pharmaceuticals LLC
    • 15.1.4. Bayer AG
    • 15.1.5. Ben Pharmaceuticals
    • 15.1.6. Centurion Laboratories Private Limited
    • 15.1.7. Cipla Ltd.
    • 15.1.8. Consern Pharma Limited
    • 15.1.9. Dr.Reddys Laboratories Inc.
    • 15.1.10. F. Hoffmann-La Roche AG
    • 15.1.11. Fredun Group
    • 15.1.12. Garcia Life Sciences
    • 15.1.13. Glaxosmithkline PLC
    • 15.1.14. Healthy Life Pharma Private Limited
    • 15.1.15. Ipca Laboratories
    • 15.1.16. Jackson Laboratories Pvt Ltd.
    • 15.1.17. Mankind Pharma
    • 15.1.18. Merck KgaA
    • 15.1.19. Novartis AG
    • 15.1.20. Sanofi
    • 15.1.21. Soigner Pharma by Arlak Biotech
    • 15.1.22. Sriwalls Health Care
    • 15.1.23. Taj Life Sciences Pvt. Ltd.
    • 15.1.24. Weefsel Pharma
    • 15.1.25. Zydus Group
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPARASITIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIPARASITIC DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIPARASITIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPARASITIC DRUGS MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIPARASITIC DRUGS MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIPARASITIC DRUGS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIPARASITIC DRUGS MARKET SIZE, BY ENDOPARACITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIPARASITIC DRUGS MARKET SIZE, BY TOPICAL CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIPARASITIC DRUGS MARKET SIZE, BY FLEAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIPARASITIC DRUGS MARKET SIZE, BY INTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIPARASITIC DRUGS MARKET SIZE, BY LICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIPARASITIC DRUGS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIPARASITIC DRUGS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIPARASITIC DRUGS MARKET SIZE, BY TICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIPARASITIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIPARASITIC DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIPARASITIC DRUGS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANTIPARASITIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 238. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. ANTIPARASITIC DRUGS MARKET LICENSE & PRICING